Status:
RECRUITING
Establishment of a Lifetime of Cohort of Adults Surviving Childhood Cancer
Lead Sponsor:
St. Jude Children's Research Hospital
Collaborating Sponsors:
National Cancer Institute (NCI)
American Society of Clinical Oncology
Conditions:
Cancer
Eligibility:
All Genders
5+ years
Brief Summary
Childhood cancer predisposes to health risks that may not become apparent until many years after completion of therapy. The SJLIFE protocol is designed to establish a lifetime cohort of childhood canc...
Detailed Description
SJLIFE will be implemented in progressive stages with specific objectives to permit knowledge gained in each phase to inform content/format/study design of subsequent stages. The planned stages of the...
Eligibility Criteria
Inclusion
- Patient will have a diagnosis of childhood malignancy (or neoplasm requiring similar therapy) that was treated or followed at St. Jude Children's Research Hospital.
- Patient will be at least five years from diagnosis.
- Patient is willing to participate at any level of study
- Patient is willing to comply with the guidelines of St. Jude domiciliary care facilities
- Patient or legally authorized representative must sign informed consent for study participation.
- Control Participant:
- ≥5 years of age
- Non-first degree relatives or friends of St. Jude patients or former patients or SJCRH employees/affiliates who are not SJLIFE study team members, or family members of SJLIFE study team, or supervised by a SJLIFE study team members, or any volunteer not associated with St. Jude.
- Participant does not have a diagnosis of childhood malignancy or childhood neoplasm requiring similar therapy (i.e., diagnosed \<21 years of age).
- Participant is not currently pregnant or lactating.
- Patient is willing to comply with the guidelines of St. Jude domiciliary care facilities.
- Patient must sign informed consent for study participation.
Exclusion
- Patient or control subject refuses to participate at any level of study
Key Trial Info
Start Date :
September 13 2007
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2035
Estimated Enrollment :
8000 Patients enrolled
Trial Details
Trial ID
NCT00760656
Start Date
September 13 2007
End Date
December 31 2035
Last Update
January 7 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Jude Children's Research Hospital
Memphis, Tennessee, United States, 38105